← Leaderboards
Jiang Bian
Weill Medical Coll Of Cornell Univ
$15,427,176
Attributed
$40,084,591
Total exposure
22
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12.1M · FY2019–25$20M$15M$10M$5M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$38,634,594 · 21
CDC$1,449,997 · 1
By mechanism
R01$19,719,322 · 8
U01$6,224,318 · 2
RF1$4,910,349 · 2
R21$3,015,789 · 5
U24$1,599,544 · 1
R56$1,560,053 · 1
Top collaborators
- Yi Guo18 shared
- Cui Tao12 shared
- Fei Wang11 shared
- Yong Chen7 shared
- Hui Hu7 shared
- Hui Shao5 shared
- Elizabeth A Shenkman5 shared
- Peter A Merkel4 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Jialin Mao$906,612
- Fei Wang$8,043,905
- Yifan Peng$3,844,321
- Andrew M Ryan$9,748,225
- Parag Goyal$4,164,920
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposElectronic Health RecordSuccessNatural Language ProcessingAffectCohortS DiseaseStructureFloridaClinical ResearchLinkStandardizationCharacteristicsFutureDesignS Disease Related DementiaMachine LearningPhenotyping AlgorithmResearch PersonnelPatternComputable PhenotypesMethodologyAlgorithmsComplex
Grant awards (58)
An end-to-end informatics framework to study Multiple Chronic Conditions (MCC)'s impact on Alzheimer's disease using harmonized electronic health records$1,111,745
R01 · FY2025 · AG
PANDA-MSD: Predictive Analytics via Networked Distributed Algorithms for Multi-System Diseases$1,102,033
U01 · FY2025 · TR
ACTS (AD Clinical Trial Simulation): Developing Advanced Informatics Approaches for an Alzheimer's Disease Clinical Trial Simulation System$973,545
R01 · FY2025 · AG
ACCELERATE-BASSO: Coordinating Center for Accelerating Behavioral and Social Science through Ontology$801,896
U24 · FY2025 · AG · contact PI
Eligibility criteria design for Alzheimer's trials with real-world data and explainable AI$754,110
R01 · FY2025 · AG
Standardizing and Harmonizing Behavioral and Social Science Research Factors in Alzheimer's Disease through Ontology-Based Approaches$752,353
U01 · FY2025 · AG
Disparities of Alzheimer's disease progression in sexual and gender minorities$750,304
R01 · FY2025 · AG
Computational Drug Repurposing for AD/ADRD with Integrative Analysis of Real World Data and Biomedical Knowledge$740,268
R01 · FY2025 · AG
iSMART: intelligent Social risk Management in AD/ADRD paTients$722,946
R01 · FY2025 · AG
Artificial Intelligence and Counterfactually Actionable Responses to End HIV (AI-CARE-HIV)$707,356
R01 · FY2025 · AI
Semantics Standards and Tools for Spatial and Contextual Exposome Data$656,380
R24 · FY2025 · ES · contact PI
PANDA-MSD: Predictive Analytics via Networked Distributed Algorithms for Multi-System Diseases$1,160,870
U01 · FY2024 · TR
An end-to-end informatics framework to study Multiple Chronic Conditions (MCC)'s impact on Alzheimer's disease using harmonized electronic health records$1,142,041
R01 · FY2024 · AG
ACTS (AD Clinical Trial Simulation): Developing Advanced Informatics Approaches for an Alzheimer's Disease Clinical Trial Simulation System$1,021,664
R01 · FY2024 · AG
Standardizing and Harmonizing Behavioral and Social Science Research Factors in Alzheimer's Disease through Ontology-Based Approaches$801,130
U01 · FY2024 · AG
ACCELERATE-BASSO: Coordinating Center for Accelerating Behavioral and Social Science through Ontology$797,648
U24 · FY2024 · AG · contact PI
Eligibility criteria design for Alzheimer's trials with real-world data and explainable AI$790,377
R01 · FY2024 · AG
Disparities of Alzheimer's disease progression in sexual and gender minorities$781,383
R01 · FY2024 · AG · contact PI
Computational Drug Repurposing for AD/ADRD with Integrative Analysis of Real World Data and Biomedical Knowledge$766,946
R01 · FY2024 · AG
iSMART: intelligent Social risk Management in AD/ADRD paTients$752,903
R01 · FY2024 · AG
Artificial Intelligence and Counterfactually Actionable Responses to End HIV (AI-CARE-HIV)$719,194
R01 · FY2024 · AI
Semantics Standards and Tools for Spatial and Contextual Exposome Data$652,915
R24 · FY2024 · ES · contact PI
Addressing Social Determinants of Health in Systemic Lupus Erythematosus$295,924
R43 · FY2024 · MD
DP20-001 Using Real-world Data to Assess the Burden of Diabetes in Children and Adolescents in Florida$249,999
U18 · FY2024 · DP · contact PI
Post-Acute Sequelae of SARS-CoV-2 Infection and Subsequent Disease Progression in Individuals with AD/ADRD: Influence of the Social and Environmental Determinants of Health$2,561,480
RF1 · FY2023 · AG
AI-ADRD: Accelerating interventions of AD/ADRD via Machine learning methods$2,348,869
RF1 · FY2023 · AG
PANDA-MSD: Predictive Analytics via Networked Distributed Algorithms for Multi-System Diseases$1,195,699
U01 · FY2023 · TR
An end-to-end informatics framework to study Multiple Chronic Conditions (MCC)'s impact on Alzheimer's disease using harmonized electronic health records$1,168,232
R01 · FY2023 · AG
ACTS (AD Clinical Trial Simulation): Developing Advanced Informatics Approaches for an Alzheimer's Disease Clinical Trial Simulation System$1,155,311
R01 · FY2023 · AG
Eligibility criteria design for Alzheimer's trials with real-world data and explainable AI$820,172
R01 · FY2023 · AG
Disparities of Alzheimer's disease progression in sexual and gender minorities$809,623
R01 · FY2023 · AG · contact PI
Computational Drug Repurposing for AD/ADRD with Integrative Analysis of Real World Data and Biomedical Knowledge$775,212
R01 · FY2023 · AG
Artificial Intelligence and Counterfactually Actionable Responses to End HIV (AI-CARE-HIV)$731,394
R01 · FY2023 · AI
The benefits and harms of lung cancer screening in Florida$327,019
R01 · FY2023 · CA · contact PI
Using Real-world Data to Assess the Burden of Diabetes in Children and Adolescents in Florida$250,000
U18 · FY2023 · DP · contact PI
PANDA-MSD: Predictive Analytics via Networked Distributed Algorithms for Multi-System Diseases$1,212,233
U01 · FY2022 · TR
Computational Drug Repurposing for AD/ADRD with Integrative Analysis of Real World Data and Biomedical Knowledge$807,473
R01 · FY2022 · AG
Advancing Drug Repositioning for Alzheimerâs Disease using Real-world Data$761,335
R56 · FY2022 · AG
Using Real-world Data to Assess the Burden of Diabetes in Children and Adolescents in Florida$450,000
U18 · FY2022 · DP · contact PI
The benefits and harms of lung cancer screening in Florida$335,070
R01 · FY2022 · CA · contact PI
Advancing Drug Repositioning for Alzheimerâs Disease using Real-world Data$798,718
R56 · FY2021 · AG
Optimizing the Population Representativeness of Older Adults in Cancer Trials$392,116
R21 · FY2021 · CA · contact PI
Examine the Effectiveness of Cancer Screening Among Patients with Alzheimerâs Disease and Related Dementias Using Real-World Data$381,250
R01 · FY2021 · CA · contact PI
Examine the risk of Alzheimer's disease in sexual and gender minorities$381,250
R21 · FY2021 · CA
The benefits and harms of lung cancer screening in Florida$336,323
R01 · FY2021 · CA · contact PI
Using Real-world Data to Assess the Burden of Diabetes in Children and Adolescents in Florida$249,999
U18 · FY2021 · DP · contact PI
The External Exposome and COVID-19 Severity$232,702
R21 · FY2021 · ES
Optimizing the Population Representativeness of Older Adults in Alzheimer's Disease and Related Dementia Clinical Trials$190,625
R21 · FY2021 · AG · contact PI
The External Exposome and COVID-19 Severity among Individuals with Alzheimerâs Disease and Related Dementias$183,099
R21 · FY2021 · ES
The External Exposome and COVID-19 Severity$1
R21 · FY2021 · ES
Using Electronic Health Records from a Large Clinical Data Research Network to Understand Cancer Burden and Cancer Risks Among Transgender and Gender Nonconforming (TGNC) Individuals$392,115
R21 · FY2020 · CA
Optimizing Alzheimer's Disease Clinical Trial Generalizability$370,841
R21 · FY2020 · AG
The benefits and harms of lung cancer screening in Florida$337,461
R01 · FY2020 · CA · contact PI
Using Real-world Data to Assess the Burden of Diabetes in Children and Adolescents in Florida$249,999
U18 · FY2020 · DP · contact PI
Optimizing the Population Representativeness of Older Adults in Alzheimer's Disease and Related Dementia Clinical Trials$228,750
R21 · FY2020 · AG · contact PI
The External Exposome and COVID-19 Severity$221,908
R21 · FY2020 · ES
Systematic Analysis of Clinical Study Generalizability Assessment Methods with Informatics$185,339
R21 · FY2020 · AG
Systematic Analysis of Clinical Study Generalizability Assessment Methods with Informatics$237,043
R21 · FY2019 · AG